1Ick L, Costerton JW, Mclean RJ, et al. Bacterial biofilms: influence on the pathogenesis and treatment of uninary tracy infections. J Antimicrob Chemother, 1994,33 : 31-41.
2Tomoku I, Kaori T, Kazufiumi H, et al. The irtfluence of azithromycin on the biotilm fonmation of Pseudomonas aerugnosa in vitro. Chemother, 1996,42: 186-191.
5Simpson JL, Powell H, Boyle M J, et al. Clarithromycin targets neutrophilic airway inflammation in refractory asthma [J]. Am J Respir Crit Care Med,2008,177(2) : 148-155.
6Tahan F, Ozcan A,Koc N. Clarithromycin in the treatment of RSV bronchiolitis : a double-blind, randomised, placebo-controlled tri- al[J]. Eur Respir J,2007,29(1) :91-97.
7Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection :the Maas- tricht Ⅲ Consensus Report[J]. Gut, 2007,56 (6) : 772-781.
8Rubin BK, Druce H, Ramirez OE, et al. Effect of clarithromycin on nasal mucus properties in healthy subjects and in patients with purulent rhinitis[J]. Am J Respir Crit Care Med, 1997,155 (6) :2018-2023.
9Lau WC,Waskell LA,Watkins PB,et al. Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation:a new drug-drug interaction[J]. Circulation, 2003,107 ( 1 ) :32-37.
10Cheng VC, Ho PL, Yuen KY. Two probable cases of serious drug interaction between clarithromycin and colchicines[J]. South Med J, 2005,98 (8) :811-813.